Dose Milnacipran Prevent Depressive Symptoms in Patients With Acute Stroke?

Recruiting

Phase N/A Results N/A

Summary of Purpose

Depression is one of the important psychiatric sequelae after stroke. The prevalence of post stroke depression (PSD) is approximately 20-40%. Depression comorbid with stroke has been found to be associated with increased disability, cognitive function decline, poorer rehabilitation outcome and higher mortality rate.We are going to conduct a trial of prevention of psot stroke depression by prescribing milnacipran...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 15 October 2008.

1 Sep 2007 21 Jan 2008 1 Sep 2010 1 Sep 2011 1 Oct 2008 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment

Contacts